Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".

Carleton, B C

Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity". [electronic resource] - Clinical pharmacology and therapeutics Aug 2014 - 158 p. digital

Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment

1532-6535

10.1038/clpt.2014.90 doi


Animals
Antineoplastic Agents--toxicity
Catechol O-Methyltransferase--genetics
Cisplatin--toxicity
Female
Hearing Loss--chemically induced
Humans
Male
Methyltransferases--genetics
Multidrug Resistance-Associated Proteins--genetics